文献速递MDS 与骨髓增殖性肿瘤造血干细胞移植与细胞治疗

骨髓纤维化患者的脾脏中存在缺陷的间充质基质细胞

The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells.
PubMed 文献 · Am J Hematol · 2018-02-08

该研究在体外扩增并表征了25例骨髓纤维化(MF)患者和13名健康受试者(HS)的脾脏间充质基质细胞(Sp-MSC)。两组细胞表型、生长动力学和分化能力相似,但MF患者的Sp-MSC表达nestin水平显著更低,体外更促进巨核细胞分化,且MMP2和FN1基因在mRNA和蛋白水平均显著上调,并出现HS来源Sp-MSC中从未检测到的遗传学异常。

要点

  • MF患者与健康受试者的脾脏MSC在表型、生长动力学和分化能力上相似。
  • MF患者脾脏MSC的nestin表达显著降低,且体外促进巨核细胞分化的程度高于正常对照。
  • MF患者脾脏MSC的MMP2和FN1在mRNA和蛋白水平均显著上调,并出现健康受试者MSC中未见的遗传学异常。

核心结论

  • MF患者的脾脏微环境存在缺陷,可能解释CD34+细胞运输增加和巨核细胞谱系扩增等病理特征。

研究设计与样本

  • 体外扩增并表征25例MF患者和13名健康受试者(HS)的脾脏间充质基质细胞(Sp-MSC)。

主要发现

  • MF患者与HS来源的Sp-MSC在表型、生长动力学和分化能力上相似。
  • MF患者Sp-MSC的nestin表达水平显著低于正常对照。
  • MF患者Sp-MSC在体外促进巨核细胞分化的程度高于正常对照。
  • MF患者Sp-MSC的MMP2和FN1基因在mRNA表达和蛋白水平均显著上调。
  • MF患者Sp-MSC出现遗传学异常,而HS来源的Sp-MSC中从未检测到这些异常。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Splenic hematopoiesis is a major feature in the course of myelofibrosis (MF). In fact, the spleen of patients with MF contains malignant hematopoietic stem cells retaining a complete differentiation program, suggesting both a pivotal role of the spleen in maintaining the disease and a tight regulation of hematopoiesis by the splenic microenvironment, in particular by mesenchymal stromal cells (MSCs). Little is known about splenic MSCs (Sp-MSCs), both in normal and in pathological context. In this work, we have in vitro expanded and characterized Sp-MSCs from 25 patients with MF and 13 healthy subjects (HS). They shared similar phenotype, growth kinetics, and differentiation capacity. However, MF Sp-MSCs expressed significant lower levels of nestin, and favored megakaryocyte (Mk) differentiation in vitro at a larger extent than their normal counterpart. Moreover, they showed a significant upregulation of matrix metalloprotease 2 (MMP2) and fibronectin 1 (FN1) genes both at mRNA expression and at protein level, and, finally, developed genetic abnormalities which were never detected in HS-derived Sp-MSCs. Our data point toward the existence of a defective splenic niche in patients with MF that could be responsible of some pathological features of the disease, including the increased trafficking of CD34+ cells and the expansion of the megakaryocytic lineage.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Avanzini MA, Abbonante V, Catarsi P, et al. The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells. Am J Hematol. 2018. PMID: 29359451. doi:10.1002/ajh.25047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。